Valneva's Shares Approach Technical Support After a 38% Decline Over Three Months

Current Session Performance

Valneva's stock has lost 3.14% compared to last Friday's close (2.68 euros), now standing at 2.591 euros. This new drop is part of a prolonged decline: the stock has lost 4.39% over the last seven days and 38.54% over three months. Over a year, the performance remains negative at -6.6%. The price is now very close to the identified support threshold at 2.58 euros. A downward breach of this level could pave the way for a continuation of the correction, with resistance significantly higher at 4.93 euros. The CAC 40 is down 0.95% at 8,181.44 points during the session, while the SBF 120 loses 0.94%, illustrating a generally unfavorable environment. In the health sector, Sanofi is down 0.60% and UCB drops 1.13%, confirming broader selling pressure on European pharmaceutical stocks.

Technical Analysis Perspective

From a technical analysis standpoint, Valneva's Relative Strength Index (RSI) stands at 29, just below the conventional oversold threshold set at 30. This level indicates intense and persistent selling pressure on the stock. Moreover, the price of 2.591 euros is significantly below its 50-day and 200-day moving averages, established at 4.03 euros and 3.88 euros respectively, confirming the medium and long-term bearish trend. Regarding the calendar, the first quarter 2026 results are expected on May 7, followed by the general meeting scheduled for June 1. These dates could act as catalysts for the stock, in one direction or another. No new elements have specifically explained the day's bearish movement, which fits into the broader trend observed over several weeks on the stock.